-
-
-
-
-
-
-
Sanofi reports positive phase 2 trial results for AATD treatment
-
-
-
-
-
-
-
Press Release: Sanofi’s lunsekimig met primary and key secondary endpoints in phase 2 respiratory studies in asthma and CRSwNP
-
-
-
-
-
-
-
Santander to acquire Webster Bank for $12.2 billion in US expansion push
-
-
-
-
-
-
-
Press Release: Sanofi’s Tzield accepted for expedited review in the US for stage 3 type 1 diabetes through FDA Commissioner's National Priority Voucher pilot program
-
-
-
-
-
-
-
Sanofi to acquire Blueprint Medicines, $129 per share
-
-
-
-
-
-
-
Press Release: Sanofi and CD&R close Opella transaction, create global consumer healthcare leader
-
-
-
-
-
-
-
Sanofi profit growth beats market view on early start of vaccine sales
-
1,217,527 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

